Lumbar Traction Devices
Customize your policy alerts
Sign up for Aetna Policy 0569 alerts
Get alerted when Policy 0569 changes without checking for updates manually.
Monitor payer policy activity
This policy governs the coverage stance for lumbar traction devices and related traction interventions for low back pain (LBP) and other indications for Aetna members. It identifies devices considered experimental/investigational and cross-references related Aetna policies.
No material clinical or coverage changes in this revision.
Coverage Criteria for Lumbar Traction Devices
Experimental/Investigational Devices
Not covered / Experimental and Investigational
Experimental/Investigational interventions
Device types considered experimental/investigational
- Autotraction devices (brand examples: Anatomotor, Arthrotonic stabilizer, Quantum 400 inter-segmental traction table, Spinalator Spinalign massage inter-segmental traction table).
- Home pneumatic lumbar traction devices (e.g., Orthotrac Pneumatic Vest; Saunders Lumbar HomeTrac; Saunders STx; DDS 500 Lumbar Traction).
- Axial spinal unloading (gravity-dependent traction) devices (e.g., LTX 3000; Triton DTS; Z-Grav Spinal Decompression Table).
- Lumbar lordotic curve-controlled traction devices (e.g., Kinetrac-9900).
- Inversion tables (e.g., Fit Spine LX9 inversion table).
HCPCS and related codes for traction devices are identified in the policy. Notably, E0830 is listed for ambulatory traction devices, L0631 is listed for a lumbar‑sacral orthosis (sagittal control), and S9090 is listed for vertebral axial decompression (per session; e.g., Triton DTS). The policy also references CPT procedure codes commonly used with traction services such as 97012 (mechanical traction) and 97140 (manual therapy techniques, including manual traction).
The policy explicitly notes that certain HCPCS-coded devices (examples given include the Z‑Grav spinal decompression table, lumbar lordotic curve‑controlled traction devices, and inversion tables such as the Fit Spine LX9) are not covered for the indications listed in this Clinical Policy Bulletin; use or billing for these devices may be subject to denial because effectiveness has not been established.
A randomized study of lordotic curve‑controlled traction (Lee et al.) had several important limitations described by the authors. Although enrollment met sample‑size targets, the study population was narrowly defined and may not generalize to broader age groups or disease severities. There was no control group of patients without disc disease, and outcomes were assessed immediately after a course of therapy (final measurement at ~15 sessions, about 1.5 months), so the trial did not provide data on durable, long‑term benefit. The authors conclude that the long‑lasting effects of traction remain undetermined and should be assessed in future studies.
Systematic reviews and authoritative assessments consistently conclude that the available evidence does not demonstrate traction to be effective for acute or chronic low back pain. Earlier technology assessments and guidelines (for example, the Norwegian Centre for Health Technology Assessment and AHCPR guideline) reported no demonstrated benefit for traction in lumbar disc herniation or acute LBP. More recent systematic reviews, including a Cochrane review, found that traction is probably not effective overall and that neither continuous nor intermittent traction alone was superior to placebo, sham, or other treatments for mixed‑duration low back pain with or without sciatica. Some reviews noted isolated findings (for example, limited evidence that autotraction may be superior to mechanical traction in certain sciatica outcomes), but these results were inconsistent and based on studies with methodological limitations.
Relevant CPT/HCPCS/ICD-10 Codes
| E0830 | Ambulatory traction device, all types, each. |
| L0631 | Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to T-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise. |
| S9090 | Vertebral axial decompression, per session [Triton DTS]. |
| M54.50 | Low back pain |
| M54.59 | Low back pain |
Provider Actions, Prior Authorization & Documentation
Denial Risk for Experimental/Investigational Devices
Use or billing for devices and procedures listed as experimental and investigational may result in claim denial. Examples include autotraction devices, home pneumatic lumbar traction devices (e.g., Orthotrac, Saunders HomeTrac), axial spinal unloading devices (e.g., LTX 3000, Triton DTS), lumbar lordotic curve-controlled traction devices (e.g., Kinetrac-9900), and inversion tables (e.g., Fit Spine LX9).
- Autotraction devices (Anatomotor, Arthrotonic stabilizer, Quantum 400, Spinalator Spinalign)
- Home pneumatic lumbar traction devices (Orthotrac, Saunders Lumbar HomeTrac, Saunders STx, DDS 500)
- Axial spinal unloading devices (LTX 3000, Triton DTS, Z-Grav Spinal Decompression Table)
- Lumbar lordotic curve-controlled traction devices (Kinetrac-9900)
- Inversion tables (Fit Spine LX9)
Documentation When Traction Is Used
Document the clinical rationale when traction is used, including indication, type of traction, force/intensity, frequency and duration of sessions, and concurrent therapies (e.g., physical therapy modalities).
- Record indication and objective findings (e.g., diagnosis, imaging when applicable)
- Specify traction type (manual, mechanical, pneumatic, autotraction, inversion, etc.)
- Document traction parameters: force/intensity, continuous vs intermittent, session length, frequency
- Note concurrent treatments provided during the same course of care
Step Therapy
No step therapy requirements are described in this policy.
Clinical Studies Summarized; No Submission Requirements Specified
This document summarizes clinical studies and investigational findings related to lumbar traction (e.g., Tadano et al. 2019; Lee et al. 2020) but does not specify submission requirements for studies or additional provider actions beyond documentation and prior authorization checks.
- Summaries describe limited evidence and methodological concerns regarding traction effectiveness
- No study submission or exception request procedures are specified in this portion of the policy
Provider Actions Not Specified in This Part of the Document
No other provider actions or specific operational steps are specified in this portion of the document. Check the payer's plan-specific requirements and related policy documents for additional instructions.
- Related policies: CPB 0180, CPB 0232, CPB 0453 may contain additional guidance
- Verify member-specific benefit and prior authorization rules
Background on Traction Therapies
Traction is widely used in the management of low back pain in multiple forms and modes, including mechanical traction, manual traction, autotraction (use of the patient’s own weight), gravity‑dependent or axial unloading devices, pneumatic systems, and continuous or intermittent application. Its proposed mechanisms—such as spinal elongation, reduction of lordosis, or increased intervertebral space—have been offered, but empirical support is limited. Traction is commonly administered in combination with other therapies, and supervised mechanical traction is typically provided up to 4 sessions per week in clinical practice.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.